Cytomx Therapeutics shares owned by BBK Capital Partners
Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by BBK Capital Partners
from 13F filings
Historical chart of BBK Capital Partners investment in Cytomx Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cytomx Therapeutics held by BBK Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cytomx Therapeutics by BBK Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $378k | 118k | 3.19 |
| 2025-06-30 | $710k | 313k | 2.27 |
| 2025-03-31 | $225k | 354k | 0.64 |
| 2024-12-31 | $394k | 383k | 1.03 |
| 2024-09-30 | $290k | 246k | 1.18 |
| 2024-06-30 | $315k | 258k | 1.22 |
| 2024-03-31 | $628k | 288k | 2.18 |
| 2023-12-31 | $475k | 306k | 1.55 |
| 2023-09-30 | $410k | 318k | 1.29 |
| 2023-06-30 | $547k | 318k | 1.72 |
| 2023-03-31 | $480k | 318k | 1.51 |
| 2022-12-31 | $509k | 318k | 1.60 |
| 2022-09-30 | $451k | 311k | 1.45 |
| 2022-06-30 | $380k | 208k | 1.83 |